Company intelligence / Profile preview
BIRMEX
- Ownership
- Private
- Employees
- ~1500
- Development stage
- Other
Overview
BIRMEX is a Mexican state-owned pharmaceutical enterprise dedicated to the research, development, production, and distribution of biological products and reagents. The company is globally recognized for its expertise in producing hyperimmune sera, particularly antivenoms for snake, scorpion, and spider bites. In addition to its manufacturing role, BIRMEX serves as a strategic pillar for the Mexican healthcare system by managing national vaccine supplies and operating large-scale logistics hubs. Recently, its mandate has expanded to include the centralized distribution of medications through the 'Megafarmacia del Bienestar' to ensure drug availability across Mexico's public health institutions. The company also engages in international technology transfers and fill-finish operations for various essential vaccines.
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- VaccineBiologicSmall molecule
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on BIRMEX.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIRMEX.